The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Strength training and albuterol in facioscapulohumeral muscular dystrophy
Abstract
BACKGROUND: In animals and healthy volunteers beta2-adrenergic agonists increase muscle strength and mass, in particular when combined with strength training. In patients with facioscapulohumeral muscular dystrophy (FSHD) albuterol may exert anabolic effects. The authors evaluated the effect of strength training and albuterol on muscle strength and volume in FSHD. METHODS: Sixty-five patients were randomized to strength training of elbow flexors and ankle dorsiflexors or non-training. After 26 weeks albuterol (sustained-release, 8 mg BID) was added in a randomized, double-blind, placebo-controlled design. Primary outcome was maximum voluntary isometric strength (MVIC) at 52 weeks. Secondary outcomes comprised dynamic strength and muscle volume. RESULTS: Training and albuterol were well tolerated. Training of elbow flexors did not result in a significant effect on MVIC, but dynamic strength improved significantly. Elbow flexor MVIC strength increased significantly in albuterol vs placebo treated patients. Ankle dorsiflexor strength decreased in all groups. Eleven out of twelve non-trained muscles in the albuterol group showed a positive effect on MVIC compared to the placebo group (p < 0.05 in seven muscle groups). Muscle volume decreased in the placebo-treated, and increased in the albuterol-treated patients. No synergistic or antagonistic effects were observed between training and albuterol. CONCLUSIONS: In FSHD strength training and albuterol appear safe interventions with limited positive effect on muscle strength and volume. Consequences of prolonged use are presently unclear, which precludes routine prescription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pollock, M. L., Gaesser, G. A., Butcher, J. D., Despr??s, J.-P., Dishman, R. K., Franklin, B. A., & Garber, C. E. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199806000-00032 · Cited by 3,051
Progression Models in Resistance Training for Healthy Adults
(2002) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200202000-00027 · Cited by 2,979
Data on the distribution of fibre types in thirty-six human muscles
Johnson, M. A., Polgar, J., Weightman, D., & Appleton, D. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90023-3 · Cited by 2,200
Cited by
Creatine kinase monitoring in sport medicine
Brancaccio, P., Maffulli, N., & Limongelli, F. M. (2007) · British Medical Bulletin · doi:10.1093/bmb/ldm014 · Cited by 937
Facioscapulohumeral muscular dystrophy
Tawil, R., & Van Der Maarel, S. M. (2006) · Muscle & Nerve · doi:10.1002/mus.20522 · Cited by 441
Self-citationRole of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Lynch, G. S., & Ryall, J. G. (2008) · Physiological Reviews · doi:10.1152/physrev.00028.2007 · Cited by 410
Strength training and aerobic exercise training for muscle disease
Voet, N. B., van der Kooi, E. L., Riphagen, I. I., Lindeman, E., van Engelen, B. G., & Geurts, A. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003907.pub4 · Cited by 327
Self-citationBoth aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: An RCT
Voet, N., Bleijenberg, G., Hendriks, J., de Groot, I., Padberg, G., van Engelen, B., & Geurts, A. (2014) · Neurology · doi:10.1212/wnl.0000000000001008 · Cited by 152
Self-citation
Metadata
- Authors
- van der Kooi, E. L., Vogels, O. J. M., van Asseldonk, R. J. G. P., Lindeman, E., Hendriks, J. C. M., Wohlgemuth, M., van der Maarel, S. M., & Padberg, G. W.
- Venue
- Neurology
- Published
- 2004-08-24
- Volume
- 63
- Issue
- 4
- Pages
- 702-708
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2065335605
- Cited by
- 166
- References
- 3
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strength training and albuterol in facioscapulohumeral muscular dystrophy. https://app.cochat.ai/papers/10.1212/01.wnl.0000134660.30793.1f
- The paper
- van der Kooi, E. L., Vogels, O. J. M., van Asseldonk, R. J. G. P., Lindeman, E., Hendriks, J. C. M., Wohlgemuth, M., van der Maarel, S. M., & Padberg, G. W. (2004). Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology. https://doi.org/10.1212/01.wnl.0000134660.30793.1f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.